Journal of Clinical and Experimental Toxicology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518-081136

Endogenous negative regulators of inflammation preserve neuronal survival

International Conference on Toxicology and Pharmacology
November 01-02, 2017 | Toronto, Canada

Denis Gris

University of Sherbrooke, Canada

Scientific Tracks Abstracts : J Clin Exp Tox

Abstract:

Cyanotoxins have been shown to be highly toxic for mammalian cells, including brain cells. However, little is known about their effect on inflammatory pathways. Our study investigated whether mammalian brain and immune cells can be a target of certain cyanotoxins, at doses approximating those in the guideline levels for drinking water. We examined the effects on cellular viability, apoptosis, and inflammation signaling of several toxins on murine macrophage-like RAW264.7, microglial BV-2, and neuroblastoma N2a cell lines. We have tested cylindrospermopsin (CYN), microcystin-LR (MCLR), and anatoxin-a (ATXa), individually as well as in mixture. Searching into protective mechanism against cyanotoxins, we found that Nlrx1, a protein localized to mitochondria, ameliorates toxin effects. Decreased expression of Nlrx1 correlated with increased vulnerability of all cell types to toxin exposure. Our results demonstrate that CYN, MC-LR, and ATX-a, at low doses individually and in mixture, have potent effect inducing apoptosis and inflammation. Further research of the neuroinflammatory effects of these compounds in-vivo is needed to improve safety limit levels for cyanotoxins in drinking water and food.

Biography:

Denis Gris has completed his PhD in the Neuroscience program at the Western University of Ontario and moved to the University of North Carolina at Chapel Hill where he studied mechanism of immune responses. His laboratory studies a role of inflammation in the development and progression of neurodegenerative disorders and using in-vitro and in-vivo models, he aims to uncover novel endogenous pathways that limit neuroinflammation. At his lab, with his co-workers, they pair molecular work with latest state-of-the-art automated behavioral assessment technology, to study how inflammation changes CNS function.

PDF HTML
Get the App